학술논문
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial
Document Type
Article
Author
Source
In: The Lancet . (The Lancet, April 2012, 379(9825):1498-1507)
Subject
Language
English
ISSN
1474547X
01406736
01406736